Skip to content

Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure

Catheter Ablation Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure: A Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02846922
Enrollment
394
Registered
2016-07-27
Start date
2016-08-31
Completion date
2016-12-31
Last updated
2023-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Catheter Ablation, Heart Failure, Rate Control

Brief summary

To evaluate the efficacy of catheter ablation and rate control in heart failure patients with atrial fibrillation.

Detailed description

All patients received either catheter ablation for rhythm control or rate control before enrollment, and the investigators do not assign specific interventions to the subjects during the study. So this study might be considered to be observational.

Interventions

None listed

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age\>18 years * documented atrial fibrillation * New York Heart Association Ⅱ-Ⅳ or left ventricular ejection fraction \<50%

Exclusion criteria

* heart failure that had a suspected reversible cause * previous ablation * any contraindication to catheter ablation

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiac eventsup to 3 yearscomposite of all-cause mortality, stroke and unplanned hospitalization due to cardiovascular reasons

Secondary

MeasureTime frameDescription
all-cause mortalityup to 3 years
strokeup to 3 yearsstroke must be certified by CT scan
unplanned hospitalization due to cardiovascular reasonsup to 3 yearsUnplanned hospitalization will be present only if the patient is hospitalized unexpectedly because of persisting or increasing complaints of heart failure and ventricular arrhythmias

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026